Figure 2
From: The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression
Immunohistochemical detection for p14ARF and p16INK4A. (A) Follicular adenoma, case 1: Increased p14ARF and p16INK4A expression in tumour (T) when compared to nontumoral tissue (N). (B) Papillary carcinoma, case 30: increased nuclear p14ARF expression in tumor (T30) when compared to nontumoral tissue (N30). Case 23: cytoplasmic delocalisation of p14ARF in tumour (T23), when compared to nontumoral (N23). N: nontumoral adjacent tissue, T: Tumour.
